Simcere Pharmaceutical Group Limited
HKEX:2096.HK
6.16 (HKD) • At close September 16, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Simcere Pharmaceutical Group Limited |
Symbool | 2096.HK |
Munteenheid | HKD |
Prijs | 6.16 |
Beurswaarde | 15,565,211,200 |
Dividendpercentage | 3.34% |
52-weken bereik | 4.94 - 7.87 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jinsheng Ren |
Website | https://www.simcere.com |
An error occurred while fetching data.
Over Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. It focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. The company's principal products include Sanbexin, an edaravone
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)